OptimizeRx Corp — Director's Dealing 2022

Nov 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2022-11-08

Reporting Person: Odence-Ford Marion (General Counsel and CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-08	Common Stock	M	1785	—	Acquired	6785	Direct
2022-11-08	Common Stock	F	710	$14.52	Disposed	6075	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-08	Restricted Stock Units	$	M	1785	Disposed	2024-11-08	Common Stock (1785.0)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

F3: On November 8, 2021, the reporting person was granted 5,355 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.